Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Wu, Pan Pan ^a,b,c   Zhang, Bing Jie ^a   Cui, Xi Ping ^a   Yang, Yang ^a   Jiang, Zheng Yun ^a   Zhou, Zhi Hong ^a   Zhong, Ying Ying ^a   Mai, Yu Ying ^a   Ouyang, Zhong ^a   Chen, Hui Sheng ^a   Zheng, Jie ^a   Zhao, Su Qing ^a,c   Zhang, Kun ^a,b,c  

^a GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

^b Wuyi University   (China)

^c International Healthcare Innovation Institute (Jiangmen)   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSIDASE INHIBITOR; TRITERPENE; URSOLIC ACID;

MOLECULAR DOCKING; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

GLYCOSIDE HYDROLASE INHIBITORS; HYPOGLYCEMIC AGENTS; MOLECULAR DOCKING SIMULATION; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 85016577178     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45578     Document Type: Article

References (32)

1. World Health Organization. Global report on diabetes. http://www.who.int/diabetes/global-report/en/ (2016).
2. Zimmet, P., Alberti, K. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782-787 (2001).
3. Shaw, J. E., Sicree, R. A. & Zimmet, P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pr. 87, 4-14 (2010).
4. World Health Organization. Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/ (2016).
5. Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3 (2006).
6. Silva, F. S. G., Oliveira, P. J. & Duarte, M. F. Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion? J. Agr. Food Chem. 64, 2991-3008 (2016).
7. Forouhi, N. G. & Wareham, N. J. Epidemiology of diabetes. Medicine (Abingdon) 42, 698-702 (2014).
8. Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E. & Kitabchi, A. E. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60, 1-23 (2011).
9. Bonora, E. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight. Int J Clin Pract Suppl. 19-28 (2007).
10. Narayan, K., Gregg, E. W., Fagot-Campagna, A., Engelgau, M. M. & Vinicor, F. Diabetes - a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res. Clin. Pr. 502, S77-S84 (2000).
11. Chouaib, K. et al. Semi-synthesis of new antimicrobial esters from the natural oleanolic and maslinic acids. Food Chem. 183, 8-17 (2015).
12. Hill, R. A. & Connolly, J. D. Triterpenoids. Nat. Prod. Rep. 29, 780-818 (2012).
13. Kowalski, R. Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. J. Agr. Food Chem. 55, 656-662 (2007).
14. Fontanay, S., Grare, M., Mayer, J., Finance, C. & Duval, R. E. Ursolic, oleanolic and betulinic acids: Antibacterial spectra and selectivity indexes. J. Ethnopharmacol. 120, 272-276 (2008).
15. Liu, J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol. 100, 92-94 (2005).
16. Kong, L. et al. Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity. Antivir. Res. 98, 44-53 (2013).
17. De Angel, R. E., Smith, S. M., Glickman, R. D., Perkins, S. N. & Hursting, S. D. Antitumor Effects of Ursolic Acid in a Mouse Model of Postmenopausal Breast Cancer. Nutr. Cancer 62, 1074-1086 (2010).
18. Chen, H. et al. Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. Eur. J. Med. Chem. 92, 648-655 (2015).
19. Rashid, S., Dar, B. A., Majeed, R., Hamid, A. & Bhat, B. A. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents. Eur. J. Med. Chem. 66, 238-245 (2013).
20. Tsai, S. & Yin, M. C. Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells. J. Food Sci. 73, H174-H178 (2008).
21. Baricevic, D. et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J. Ethnopharmacol. 75, 125-132 (2001).
22. Somova, L. O., Nadar, A., Rammanan, P. & Shode, F. O. Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 10, 115-121 (2003).
23. Kashyap, D., Tuli, H. S. & Sharma, A. K. Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sci. 146, 201-213 (2016).
24. Patlolla, J. M. & Rao, C. V. Triterpenoids for cancer prevention and treatment: current status and future prospects. Curr Pharm Biotechnol 13, 147-155 (2012).
25. Petronelli, A., Pannitteri, G. & Testa, U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20, 880-892 (2009).
26. Wu, P. P., Zhang, K., Lu, Y. J., He, P. & Zhao, S. Q. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur. J. Med. Chem. 80, 502-508 (2014).
27. Wu, P. et al. Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent. PLoS One 10, e138767 (2015).
28. Huang, T. et al. A hydrophilic conjugate approach toward the design and synthesis of ursolic acid derivatives as potential antidiabetic agent. RSC Adv. 5, 44234-44246 (2015).
29. Worawalai, W., Wacharasindhu, S. & Phuwapraisirisan, P. N-Arylmethylaminoquercitols, a new series of effective antidiabetic agents having alpha-glucosidase inhibition and antioxidant activity. Bioorg. Med. Chem. Lett. 25, 2570-2573 (2015).
30. Ferreira, S. B. et al. Synthesis, biological activity, and molecular modeling studies of 1H-1, 2, 3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors. J. Med. Chem. 53, 2364-2375 (2010).
31. Larkin, M. A. et al. Clustal W and clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
32. Worawalai, W., Wacharasindhu, S. & Phuwapraisirisan, P. Synthesis of new N-substituted aminoquercitols from naturally available (+ )-proto-quercitol and their alpha-glucosidase inhibitory activity. Med Chem Comm 3, 1466-1470 (2012).